Libra Infusions Limited reported unaudited earnings results for the first quarter ended September 30, 2017. For the quarter, the company's LPS was BDT 7.04 as against BDT 5.79 for July-September, 2016. Net operating cash flow per share was BDT 6.87 as against net operating cash used per share of BDT 0.70 for July-September, 2016. NAV per share was BDT 1,571 as on September 30, 2017 and BDT 1,578 as on June 30, 2017.